PMID- 24370836 OWN - NLM STAT- MEDLINE DCOM- 20140225 LR - 20140130 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 55 IP - 1 DP - 2014 Jan 29 TI - Effect of coadministration of neuronal growth factors on neuroglial differentiation of bone marrow-derived stem cells in the ischemic retina. PG - 502-12 LID - 10.1167/iovs.13-12223 [doi] AB - PURPOSE: Brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) have limited and transient supportive effects on retinal recovery from ischemia. The aim of this study was to investigate their effect on engrafted adult bone marrow-derived stem cells in a rodent model of anterior ischemic optic neuropathy (rAION). METHODS: Small cells were isolated from the bone marrow of green fluorescent protein expressing mice by counterflow centrifugal elutriation, depleted of cells expressing lineage markers, and grafted in conjunction with growth factors into the vitreous body of mice with unilateral rAION. Progenitors were mobilized with granulocyte macrophage colony-stimulating factor (GM-CSF) or stem cell factor (SCF). The contralateral eye served as a control. RESULTS: At 4 weeks, the quantitative incorporation of donor cells in the injured retina was increased by BDNF (P < 0.01 versus control) and decreased by CNTF (P < 0.01 versus control), with no notable difference at 24 weeks. Both growth factors improved the short-term and long-term qualitative engraftment of cells adopting neural phenotypes in the retinal ganglion cell (RGC) layer and astrocyte phenotypes in the anterior vasculature. The RGC-engrafted cells formed extensions toward the inner nuclear layer. In the presence of growth factors, donor cells migrated to the optic nerve and contributed to repair by gliosis. Mobilization with GM-CSF restricted cell fate to microglia, whereas SCF was associated with limited neuroglial differentiation. CONCLUSIONS: Both BDNF and CNTF enhance engraftment and neuroglial differentiation of adult bone marrow stem cells in injured retina, with BDNF having an early quantitative and qualitative advantage over CNTF. Mobilization with differentiation factors restricts cell fate in the injured retina. FAU - Goldenberg-Cohen, Nitza AU - Goldenberg-Cohen N AD - The Krieger Eye Research Laboratory, Felsenstein Medical Research Center, Petach Tikva, Israel. FAU - Avraham-Lubin, Bat-Chen R AU - Avraham-Lubin BC FAU - Sadikov, Tamilla AU - Sadikov T FAU - Askenasy, Nadir AU - Askenasy N LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140129 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ciliary Neurotrophic Factor) SB - IM MH - Animals MH - Bone Marrow Cells/*cytology/drug effects MH - Brain-Derived Neurotrophic Factor/*administration & dosage MH - Cell Count MH - Ciliary Neurotrophic Factor/*administration & dosage MH - Disease Models, Animal MH - Drug Therapy, Combination MH - Immunohistochemistry MH - Mice MH - Mice, Inbred C57BL MH - Optic Neuropathy, Ischemic/pathology/*therapy MH - *Stem Cell Transplantation MH - Treatment Outcome OTO - NOTNLM OT - bone marrow-derived stem cells (BMSC) OT - cell migration OT - mouse model OT - neuronal growth factors OT - stem cell differentiation EDAT- 2013/12/29 06:00 MHDA- 2014/02/26 06:00 CRDT- 2013/12/28 06:00 PHST- 2013/12/28 06:00 [entrez] PHST- 2013/12/29 06:00 [pubmed] PHST- 2014/02/26 06:00 [medline] AID - iovs.13-12223 [pii] AID - 10.1167/iovs.13-12223 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2014 Jan 29;55(1):502-12. doi: 10.1167/iovs.13-12223.